Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Rogers

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Medicinal Chemistry|July 1, 2015
DARC: Mapping Surface Topography by Ray-Casting for Effective Virtual Screening at Protein Interaction SitesRagul Gowthaman, Sven A Miller, Steven Rogers, et al.
Biomaterials|May 14, 2015
Inhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticlesVellaisamy Selvaraj, Niraj Nepal, Steven Rogers, et al.
Data in Brief|July 29, 2015
Lipopolysaccharide induced MAP kinase activation in RAW 264.7 cells attenuated by cerium oxide nanoparticlesVellaisamy Selvaraj, Niraj Nepal, Steven Rogers, et al.
Data in Brief|July 29, 2015
Cerium oxide nanoparticles inhibit lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsisVellaisamy Selvaraj, Niraj Nepal, Steven Rogers, et al.
Heart, Lung & Circulation|March 18, 2022
Deep Vein Thrombosis is Common After Cardiac Ablation and Pre-Procedural D-Dimer Could Predict RiskCharo Bruce, Karan Saraf, Steven Rogers, et al.
BMC Cancer|August 12, 2018
Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteinsLan Lan, Hao Liu, Amber R Smith, et al.
Journal of Medicinal Chemistry|May 5, 2016
Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosisBen Gold, Robert Smith, Quyen Nguyen, et al.
BMJ Open|February 17, 2024
Evaluating pharmacological THRomboprophylaxis in Individuals undergoing superficial endoVEnous treatment across NHS and private clinics in the UK: a multi-centre, assessor-blind, randomised controlled trial-THRIVE trialMatthew Machin, Sarah Whittley, John Norrie, et al.
Molecular Oncology|May 3, 2015
Natural product (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1Lan Lan, Carl Appelman, Amber R Smith, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Medicinal Chemistry|July 1, 2015
DARC: Mapping Surface Topography by Ray-Casting for Effective Virtual Screening at Protein Interaction SitesRagul Gowthaman, Sven A Miller, Steven Rogers, et al.
Biomaterials|May 14, 2015
Inhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticlesVellaisamy Selvaraj, Niraj Nepal, Steven Rogers, et al.
Data in Brief|July 29, 2015
Lipopolysaccharide induced MAP kinase activation in RAW 264.7 cells attenuated by cerium oxide nanoparticlesVellaisamy Selvaraj, Niraj Nepal, Steven Rogers, et al.
Data in Brief|July 29, 2015
Cerium oxide nanoparticles inhibit lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsisVellaisamy Selvaraj, Niraj Nepal, Steven Rogers, et al.
Heart, Lung & Circulation|March 18, 2022
Deep Vein Thrombosis is Common After Cardiac Ablation and Pre-Procedural D-Dimer Could Predict RiskCharo Bruce, Karan Saraf, Steven Rogers, et al.
BMC Cancer|August 12, 2018
Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteinsLan Lan, Hao Liu, Amber R Smith, et al.
Journal of Medicinal Chemistry|May 5, 2016
Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosisBen Gold, Robert Smith, Quyen Nguyen, et al.
BMJ Open|February 17, 2024
Evaluating pharmacological THRomboprophylaxis in Individuals undergoing superficial endoVEnous treatment across NHS and private clinics in the UK: a multi-centre, assessor-blind, randomised controlled trial-THRIVE trialMatthew Machin, Sarah Whittley, John Norrie, et al.
Molecular Oncology|May 3, 2015
Natural product (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1Lan Lan, Carl Appelman, Amber R Smith, et al.
Pageof 4